Szukaj
close

Witamy w firmie Atos Medical

Proszę wybrać swój kraj

Polska
Europe
Belgique (Français)
België (Nederlands)
Danmark
Deutschland
España
France
Italia
Nederland
Norge
Polska
Portugal
Schweiz (Deutsch)
Suisse (Français)
Suomi
Sverige
UK (English)
Asia
中文(大中華)
日本語 (Japan)
Americas
Brazil
Canada (English)
Canada (French)
USA (English)
Oceania
Australia (English)
New Zealand (English)
Other
International
Potwierdź swój wybór
  • Twój kraj :Polska

Panel Discussion: Tracheostomy Care in the Hospital and Community during COVID-19

In response to the COVID-19 pandemic, there have been significant shifts in recommendations for managing tracheostomy patients both in the hospital and in the community. These recommendations include changes in surgical procedures, airway management, weaning, and instrumental assessments in COVID positive as well as COVID negative patients. Limiting or eliminating any aerosol generating procedure (AGP) with the goal to protect both patients and health care providers during this crisis has been crucial. With countries and clinics opening back up, new questions and considerations arise on how to do this safely.

International panel: 

Dr Azor Carreras Alcaraz, MD.
Otolaryngologist, Althaia Xarxa Assistencial Universitària de Manresa, Barcelona, Spain

Miss Louise Edwards, BSc (Hons).
Consultant Speech and Language Therapist, The Children’s Trust, Tadworth, Surrey, UK

Prof Dr Thomas Hoffmann, MD, PhD.
Otolaryngologist and Medical Director of the ENT clinic, University Hospital Ulm, Ulm, Germany

Mr Asit Arora, PhD, DIC, DOHNS, FRCS(ORL-HNS).
ENT Airway Robotic Head and Neck Surgeon, Guys’ and St Thomas’ Hospitals, London, UK

Mrs Keri Danziger, MA
CCC-SLP Supervisor, Adult Inpatient Speech and Swallowing Services, Rusk Rehabilitation, New York University, New York, NY, USA